EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Establishment of a Novel In Vitro and In Vivo Model to Understand Molecular Carcinogenesis of Endometriosis-Related Ovarian Neoplasms

Hasibul Islam Sohel iD, Tohru Kiyono iD, Umme Farzana Zahan iD, Sultana Razia, Masako Ishikawa, Hitomi Yamashita, Kosuke Kanno, Shahataj Begum Sonia iD, Kentaro Nakayama iD, Satoru Kyo iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26051995 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Hasibul Islam Sohel und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Faculty of Medicine, Shimane University, Izumo 693-8501, Japan. Hauptthemen laut MEDLINE: Endometriosis, Ovarian Neoplasms, Carcinogenesis. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: JSPS KAKENHI, S-SPRING (Japan Science and Technology Agency (JST).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The molecular mechanisms through which endometriosis-related ovarian neoplasms (ERONs) develop from benign endometrioma remain unclear. It is especially a long-standing mystery why ovarian endometrioma has the potential to develop into two representative histological subtypes: endometrioid ovarian carcinoma or clear cell ovarian carcinoma. This study aimed to investigate the molecular carcinogenesis of ERONs using newly developed in vitro and in vivo carcinogenesis models. Epithelial cells were isolated and purified from surgically removed benign endometrioma samples, followed by immortalization by overexpressing cyclinD1/CDK4 in combination with the human TERT gene. Immortalized cells were subjected to various molecular manipulations by combining knockout or overexpression of several candidate drivers, including ARID1A, KRAS, PIK3CA, AKT, and MYC, based on previous comprehensive genome-wide studies of ERONs. These cells were then inoculated into immunocompromised mice and evaluated for malignant transformation. Inoculated cells harboring a combination of three genetic alterations successfully developed tumors with malignant features in mice, whereas those with two genetic manipulations failed to do so. Especially, ARID1A gene knockout, combined with overexpressing the KRAS oncogenic mutant allele (or overexpressing AKT) and c-Myc overexpression led to efficient tumor formation. Of note, these three combinations of genetic alterations produced tumors that histologically represented typical clear cell carcinoma in SCID mice, while the same combination led to tumors with endometrioid histology in nude mice. A combination of ARID1A mutation, KRAS mutation or AKT activation, and c-Myc overexpression were confirmed to be the main candidate drivers for the development of ERONs, as suggested by comprehensive genetic analyses of ERONs. A tumor immune microenvironment involving B-cell signaling may contribute to the diverse histological phenotypes. The present model may help to clarify the molecular mechanisms of ERON carcinogenesis and understand their histological diversity and novel molecular targets.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EndometriosisOvarian NeoplasmsCarcinogenesisFemaleAnimalsHumansMiceCell Transformation, NeoplasticTranscription FactorsDisease Models, AnimalDNA-Binding ProteinsProto-Oncogene Proteins p21(ras)

Stichwörter der Autor:innen

ERONscarcinogenesisclear cell carcinomaendometrioid carcinomaendometriosistumor immune microenvironment

Substanzen

ARID1A protein, humanTranscription FactorsDNA-Binding ProteinsProto-Oncogene Proteins p21(ras)

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Faculty of Medicine, Shimane University, Izumo 693-8501, Japan.
  • Exploratory Oncology Research and Clinical Trial Center (EPOC), National Cancer Center, Kashiwa 277-8577, Japan.
  • Department of Legal Medicine, Shimane University Faculty of Medicine, 89-1 Enya-Cho, Izumo 693-8501, Japan.
  • Department of Obstetrics and Gynecology, East Medical Center, Nagoya City University, Nagoya 464-8547, Japan.

ORCID-Profile: Hasibul Islam Sohel, Tohru Kiyono, Umme Farzana Zahan, Shahataj Begum Sonia, Kentaro Nakayama, Satoru Kyo

Förderung

  • JSPS KAKENHI
  • S-SPRING (Japan Science and Technology Agency (JST)

Zitieren

APA

Sohel, H. I., Kiyono, T., Zahan, U. F., Razia, S., Ishikawa, M., Yamashita, H., Kanno, K., Sonia, S. B., Nakayama, K., & Kyo, S. (2025). Establishment of a Novel In Vitro and In Vivo Model to Understand Molecular Carcinogenesis of Endometriosis-Related Ovarian Neoplasms. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26051995

Vancouver

Sohel HI, Kiyono T, Zahan UF, Razia S, Ishikawa M, Yamashita H, et al. Establishment of a Novel In Vitro and In Vivo Model to Understand Molecular Carcinogenesis of Endometriosis-Related Ovarian Neoplasms. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26051995

BibTeX
@article{Sohel2025,
  author = {Sohel, Hasibul Islam and Kiyono, Tohru and Zahan, Umme Farzana and Razia, Sultana and Ishikawa, Masako and Yamashita, Hitomi and Kanno, Kosuke and Sonia, Shahataj Begum and Nakayama, Kentaro and Kyo, Satoru},
  title = {Establishment of a Novel In Vitro and In Vivo Model to Understand Molecular Carcinogenesis of Endometriosis-Related Ovarian Neoplasms},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26051995}
}
Kostenlos starten →